Withus Pharmaceutical Co Ltd is Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company's main products include circulatory agents, musculoskeletal agents, digestive agents, antibiotics and other prescription drugs. And the Company is engaged in contract manufacturing operation(CMO).

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
21/10/26	₩6,860.00	+1.63%	17,167
20/10/26	₩6,750.00	-2.60%	69,705
19/10/26	₩6,930.00	+1.91%	30,889
16/10/26	₩6,800.00	+4.13%	37,764
15/10/26	₩6,530.00	-2.97%	69,842

End-of-day quote Korea S.E.

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - WITHUS PHARMACEUTICAL Co.,LTD.

Company calendar

End-of-day quote Korea S.E. 21/10/2026			5-day change	1st Jan Change
6,860.00 ^KRW	+1.63%		+1.93%	-20.42%

15/05/23	WITHUS PHARMACEUTICAL Co.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
30/06/20	Withuspharmaceutical Co.,Ltd. has completed an IPO in the amount of KRW 25.44 billion.	CI

Market Cap	90.55B 68.2M 60.77M 56.27M 50.92M 95.93M 6.44B 97.07M 675M 265M 3.38B 256M 251M 10.78B	P/E 2024	19.4x	P/E 2025	22.9x
Enterprise Value	89.83B 67.66M 60.29M 55.82M 50.52M 95.17M 6.38B 96.3M 669M 263M 3.36B 254M 249M 10.69B	EV / Sales 2024	0.96x	EV / Sales 2025	1.06x
Free-Float	46.45%	Yield 2024 *	-	Yield 2025	-

15/05/23	WITHUS PHARMACEUTICAL Co.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
30/06/20	Withuspharmaceutical Co.,Ltd. has completed an IPO in the amount of KRW 25.44 billion.	CI
19/12/19	Withuspharmaceutical Co.,Ltd. has filed an IPO.	CI

1 day	+1.63%
1 week	+1.93%
Current month	-4.72%
1 month	-6.79%
3 months	+9.24%
6 months	-30.07%
Current year	-20.42%

WITHUS PHARMACEUTICAL Co.,LTD. Share Price

Stocks

A330350

KR7330350000

Pharmaceuticals

Valuation: WITHUS PHARMACEUTICAL Co.,LTD.

Chart: WITHUS PHARMACEUTICAL Co.,LTD.

Latest news: WITHUS PHARMACEUTICAL Co.,LTD.

Quotes and Performance

Price Extremes

Managers and Directors: WITHUS PHARMACEUTICAL Co.,LTD.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

1 week	6,560	7,160
1 month	6,480	7,370
Current year	5,910	11,950
1 year	5,910	11,950
3 years	5,610	13,680
5 years	5,610	16,100
10 years	5,610	27,233.33

Manager	Title	Age	Since
Dae-Young Sung CEO	Chief Executive Officer	67	-
Hong-Yeol Lee PRN	Corporate Officer/Principal	49	28/03/2024
Kwang-Young Kwon PRN	Corporate Officer/Principal	65	-

Director	Title	Age	Since
Dae-Young Sung BRD	Director/Board Member	67	-
Kwang-Young Kwon BRD	Director/Board Member	65	-
Chan-Mo Jeong BRD	Director/Board Member	65	27/03/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WITHUS PHARMACEUTICAL CO.,LTD.	+1.63%	+1.93%	+1.03%	-18.04%	68.2M
ELI LILLY AND COMPANY	-1.01%	+5.13%	+58.93%	+117.36%	1,133B
JOHNSON & JOHNSON	-0.61%	+1.52%	+34.34%	+68.48%	621B
ABBVIE INC.	-1.48%	+0.47%	+23.08%	+94.76%	503B
ROCHE HOLDING AG	-0.80%	+2.29%	+38.47%	+63.50%	379B
MERCK & CO., INC.	+1.07%	+1.70%	+71.06%	+45.98%	370B
NOVARTIS AG	+0.65%	+1.56%	+21.93%	+51.31%	292B
ASTRAZENECA PLC	+0.36%	-0.43%	+0.83%	+25.19%	262B
AMGEN INC.	-0.14%	+2.87%	+45.56%	+57.22%	237B
GILEAD SCIENCES, INC.	-1.88%	+0.02%	+23.77%	+97.39%	190B
Average	+0.42%	+3.40%	+31.90%	+60.32%	398.81B
Weighted average by Cap.	+0.58%	+3.73%	+40.75%	+79.73%

	2024	2025
Net sales	103B 77.37M 68.94M 63.83M 57.76M 109M 7.3B 110M 765M 300M 3.84B 290M 284M 12.23B	106B 80.17M 71.44M 66.14M 59.86M 113M 7.57B 114M 793M 311M 3.98B 301M 294M 12.67B
Net income	4.78B 3.6M 3.21M 2.97M 2.69M 5.07M 340M 5.13M 35.65M 13.99M 179M 13.52M 13.24M 570M	4.97B 3.74M 3.33M 3.09M 2.79M 5.26M 353M 5.32M 37.01M 14.52M 186M 14.03M 13.74M 591M
Net Debt	5.17B 3.9M 3.47M 3.21M 2.91M 5.48M 368M 5.54M 38.53M 15.12M 193M 14.61M 14.31M 616M	-716M -539K -481K -445K -403K -759K -50.89M -768K -5.33M -2.09M -26.75M -2.02M -1.98M -85.25M